David Toung
Stock Analyst at Argus Research
(3.39)
# 1,001
Out of 5,115 analysts
130
Total ratings
66%
Success rate
10.51%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Downgrades: Hold | n/a | $74.93 | - | 3 | Jan 12, 2026 | |
| TECH Bio-Techne | Maintains: Buy | $65 → $68 | $64.09 | +6.10% | 4 | Nov 20, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $578.61 | +5.43% | 8 | Oct 29, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $102.96 | +11.69% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $195.20 | +44.46% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $345.74 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $42.20 | +23.22% | 1 | Jul 1, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $286.93 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $11.14 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $223.01 | - | 6 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $214.88 | -41.83% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $210.48 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $341.88 | -0.55% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $831.21 | -19.39% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $87.07 | +72.28% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $1,037.15 | -19.01% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $78.97 | +39.29% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $271.52 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.44 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $369.56 | -16.12% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $488.27 | -36.51% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $504.22 | -36.54% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $109.30 | +23.51% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $141.95 | -47.16% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $55.05 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $110.27 | -0.24% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.45 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $92.77 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $148.68 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $227.25 | -31.79% | 4 | Mar 27, 2020 |
Hologic
Jan 12, 2026
Downgrades: Hold
Price Target: n/a
Current: $74.93
Upside: -
Bio-Techne
Nov 20, 2025
Maintains: Buy
Price Target: $65 → $68
Current: $64.09
Upside: +6.10%
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $578.61
Upside: +5.43%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $102.96
Upside: +11.69%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $195.20
Upside: +44.46%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $345.74
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $42.20
Upside: +23.22%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $286.93
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $11.14
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $223.01
Upside: -
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $214.88
Upside: -41.83%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $210.48
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $341.88
Upside: -0.55%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $831.21
Upside: -19.39%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $87.07
Upside: +72.28%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $1,037.15
Upside: -19.01%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $78.97
Upside: +39.29%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $271.52
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $26.44
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $369.56
Upside: -16.12%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $488.27
Upside: -36.51%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $504.22
Upside: -36.54%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $109.30
Upside: +23.51%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $141.95
Upside: -47.16%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $55.05
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $110.27
Upside: -0.24%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $5.45
Upside: -
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $92.77
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $148.68
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $227.25
Upside: -31.79%